tiprankstipranks
Imunon announces results from End-of-Phase 2 meeting with FDA for IMNN-001
PremiumThe FlyImunon announces results from End-of-Phase 2 meeting with FDA for IMNN-001
3M ago
Imunon, Inc. Reports Q3 2024 Earnings and Progress
Premium
Company Announcements
Imunon, Inc. Reports Q3 2024 Earnings and Progress
4M ago
Imunon presents data from Phase 2 OVATION 2 clinical trial
Premium
The Fly
Imunon presents data from Phase 2 OVATION 2 clinical trial
4M ago
Imunon reports inducement grant under NASDAQ listing rule
PremiumThe FlyImunon reports inducement grant under NASDAQ listing rule
5M ago
Imunon Welcomes Susan Eylward as General Counsel, Strengthens Leadership Team
Premium
Company Announcements
Imunon Welcomes Susan Eylward as General Counsel, Strengthens Leadership Team
5M ago
Imunon initiated with a Buy at EF Hutton
Premium
The Fly
Imunon initiated with a Buy at EF Hutton
5M ago
Imunon reports Q2 EPS (51c), consensus (54c)
PremiumThe FlyImunon reports Q2 EPS (51c), consensus (54c)
6M ago
IMNN Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
IMNN Upcoming Earnings Report: What to Expect?
6M ago
Imunon price target lowered to $12 from $15 at Alliance Global Partners
Premium
The Fly
Imunon price target lowered to $12 from $15 at Alliance Global Partners
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100